The global Colloids (Blood Plasma) market was valued at 438.03 Million USD in 2020 and will grow with a CAGR of 2.59% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch. The global colloids (blood plasma) industry is mature. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.
By Market Verdors:
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
By Types:
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
By Applications:
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Colloids (Blood Plasma) Market Size Analysis from 2022 to 2027
1.5.1 Global Colloids (Blood Plasma) Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Colloids (Blood Plasma) Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Colloids (Blood Plasma) Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Colloids (Blood Plasma) Industry Impact
Chapter 2 Global Colloids (Blood Plasma) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Colloids (Blood Plasma) (Volume and Value) by Type
2.1.1 Global Colloids (Blood Plasma) Consumption and Market Share by Type (2016-2021)
2.1.2 Global Colloids (Blood Plasma) Revenue and Market Share by Type (2016-2021)
2.2 Global Colloids (Blood Plasma) (Volume and Value) by Application
2.2.1 Global Colloids (Blood Plasma) Consumption and Market Share by Application (2016-2021)
2.2.2 Global Colloids (Blood Plasma) Revenue and Market Share by Application (2016-2021)
2.3 Global Colloids (Blood Plasma) (Volume and Value) by Regions
2.3.1 Global Colloids (Blood Plasma) Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Colloids (Blood Plasma) Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Colloids (Blood Plasma) Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Colloids (Blood Plasma) Consumption by Regions (2016-2021)
4.2 North America Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
4.10 South America Colloids (Blood Plasma) Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Colloids (Blood Plasma) Market Analysis
5.1 North America Colloids (Blood Plasma) Consumption and Value Analysis
5.1.1 North America Colloids (Blood Plasma) Market Under COVID-19
5.2 North America Colloids (Blood Plasma) Consumption Volume by Types
5.3 North America Colloids (Blood Plasma) Consumption Structure by Application
5.4 North America Colloids (Blood Plasma) Consumption by Top Countries
5.4.1 United States Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
5.4.2 Canada Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
5.4.3 Mexico Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 6 East Asia Colloids (Blood Plasma) Market Analysis
6.1 East Asia Colloids (Blood Plasma) Consumption and Value Analysis
6.1.1 East Asia Colloids (Blood Plasma) Market Under COVID-19
6.2 East Asia Colloids (Blood Plasma) Consumption Volume by Types
6.3 East Asia Colloids (Blood Plasma) Consumption Structure by Application
6.4 East Asia Colloids (Blood Plasma) Consumption by Top Countries
6.4.1 China Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
6.4.2 Japan Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
6.4.3 South Korea Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 7 Europe Colloids (Blood Plasma) Market Analysis
7.1 Europe Colloids (Blood Plasma) Consumption and Value Analysis
7.1.1 Europe Colloids (Blood Plasma) Market Under COVID-19
7.2 Europe Colloids (Blood Plasma) Consumption Volume by Types
7.3 Europe Colloids (Blood Plasma) Consumption Structure by Application
7.4 Europe Colloids (Blood Plasma) Consumption by Top Countries
7.4.1 Germany Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.2 UK Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.3 France Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.4 Italy Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.5 Russia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.6 Spain Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.7 Netherlands Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.8 Switzerland Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
7.4.9 Poland Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 8 South Asia Colloids (Blood Plasma) Market Analysis
8.1 South Asia Colloids (Blood Plasma) Consumption and Value Analysis
8.1.1 South Asia Colloids (Blood Plasma) Market Under COVID-19
8.2 South Asia Colloids (Blood Plasma) Consumption Volume by Types
8.3 South Asia Colloids (Blood Plasma) Consumption Structure by Application
8.4 South Asia Colloids (Blood Plasma) Consumption by Top Countries
8.4.1 India Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
8.4.2 Pakistan Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Colloids (Blood Plasma) Market Analysis
9.1 Southeast Asia Colloids (Blood Plasma) Consumption and Value Analysis
9.1.1 Southeast Asia Colloids (Blood Plasma) Market Under COVID-19
9.2 Southeast Asia Colloids (Blood Plasma) Consumption Volume by Types
9.3 Southeast Asia Colloids (Blood Plasma) Consumption Structure by Application
9.4 Southeast Asia Colloids (Blood Plasma) Consumption by Top Countries
9.4.1 Indonesia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.2 Thailand Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.3 Singapore Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.4 Malaysia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.5 Philippines Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.6 Vietnam Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
9.4.7 Myanmar Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 10 Middle East Colloids (Blood Plasma) Market Analysis
10.1 Middle East Colloids (Blood Plasma) Consumption and Value Analysis
10.1.1 Middle East Colloids (Blood Plasma) Market Under COVID-19
10.2 Middle East Colloids (Blood Plasma) Consumption Volume by Types
10.3 Middle East Colloids (Blood Plasma) Consumption Structure by Application
10.4 Middle East Colloids (Blood Plasma) Consumption by Top Countries
10.4.1 Turkey Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.3 Iran Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.5 Israel Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.6 Iraq Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.7 Qatar Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.8 Kuwait Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
10.4.9 Oman Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 11 Africa Colloids (Blood Plasma) Market Analysis
11.1 Africa Colloids (Blood Plasma) Consumption and Value Analysis
11.1.1 Africa Colloids (Blood Plasma) Market Under COVID-19
11.2 Africa Colloids (Blood Plasma) Consumption Volume by Types
11.3 Africa Colloids (Blood Plasma) Consumption Structure by Application
11.4 Africa Colloids (Blood Plasma) Consumption by Top Countries
11.4.1 Nigeria Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
11.4.2 South Africa Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
11.4.3 Egypt Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
11.4.4 Algeria Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
11.4.5 Morocco Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 12 Oceania Colloids (Blood Plasma) Market Analysis
12.1 Oceania Colloids (Blood Plasma) Consumption and Value Analysis
12.2 Oceania Colloids (Blood Plasma) Consumption Volume by Types
12.3 Oceania Colloids (Blood Plasma) Consumption Structure by Application
12.4 Oceania Colloids (Blood Plasma) Consumption by Top Countries
12.4.1 Australia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
12.4.2 New Zealand Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 13 South America Colloids (Blood Plasma) Market Analysis
13.1 South America Colloids (Blood Plasma) Consumption and Value Analysis
13.1.1 South America Colloids (Blood Plasma) Market Under COVID-19
13.2 South America Colloids (Blood Plasma) Consumption Volume by Types
13.3 South America Colloids (Blood Plasma) Consumption Structure by Application
13.4 South America Colloids (Blood Plasma) Consumption Volume by Major Countries
13.4.1 Brazil Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.2 Argentina Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.3 Columbia Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.4 Chile Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.5 Venezuela Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.6 Peru Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
13.4.8 Ecuador Colloids (Blood Plasma) Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Colloids (Blood Plasma) Business
14.1 CSL Behring
14.1.1 CSL Behring Company Profile
14.1.2 CSL Behring Colloids (Blood Plasma) Product Specification
14.1.3 CSL Behring Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Baxter
14.2.1 Baxter Company Profile
14.2.2 Baxter Colloids (Blood Plasma) Product Specification
14.2.3 Baxter Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Grifols
14.3.1 Grifols Company Profile
14.3.2 Grifols Colloids (Blood Plasma) Product Specification
14.3.3 Grifols Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Octapharma
14.4.1 Octapharma Company Profile
14.4.2 Octapharma Colloids (Blood Plasma) Product Specification
14.4.3 Octapharma Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Kedrion
14.5.1 Kedrion Company Profile
14.5.2 Kedrion Colloids (Blood Plasma) Product Specification
14.5.3 Kedrion Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Shanghai Raas
14.6.1 Shanghai Raas Company Profile
14.6.2 Shanghai Raas Colloids (Blood Plasma) Product Specification
14.6.3 Shanghai Raas Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 CTBB
14.7.1 CTBB Company Profile
14.7.2 CTBB Colloids (Blood Plasma) Product Specification
14.7.3 CTBB Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Hualan Bio
14.8.1 Hualan Bio Company Profile
14.8.2 Hualan Bio Colloids (Blood Plasma) Product Specification
14.8.3 Hualan Bio Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Rongsheng Pharmaceutical
14.9.1 Rongsheng Pharmaceutical Company Profile
14.9.2 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Specification
14.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Boya Rongsheng
14.10.1 Boya Rongsheng Company Profile
14.10.2 Boya Rongsheng Colloids (Blood Plasma) Product Specification
14.10.3 Boya Rongsheng Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 B. Braun Medical
14.11.1 B. Braun Medical Company Profile
14.11.2 B. Braun Medical Colloids (Blood Plasma) Product Specification
14.11.3 B. Braun Medical Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Fresenius Kabi
14.12.1 Fresenius Kabi Company Profile
14.12.2 Fresenius Kabi Colloids (Blood Plasma) Product Specification
14.12.3 Fresenius Kabi Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 HOSPIRA
14.13.1 HOSPIRA Company Profile
14.13.2 HOSPIRA Colloids (Blood Plasma) Product Specification
14.13.3 HOSPIRA Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Axa parenterals
14.14.1 Axa parenterals Company Profile
14.14.2 Axa parenterals Colloids (Blood Plasma) Product Specification
14.14.3 Axa parenterals Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Fresenius Kabi(China)
14.15.1 Fresenius Kabi(China) Company Profile
14.15.2 Fresenius Kabi(China) Colloids (Blood Plasma) Product Specification
14.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 CR Double-Crane
14.16.1 CR Double-Crane Company Profile
14.16.2 CR Double-Crane Colloids (Blood Plasma) Product Specification
14.16.3 CR Double-Crane Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Kelun Group
14.17.1 Kelun Group Company Profile
14.17.2 Kelun Group Colloids (Blood Plasma) Product Specification
14.17.3 Kelun Group Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Shandong Qidu Pharmaceutical
14.18.1 Shandong Qidu Pharmaceutical Company Profile
14.18.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Specification
14.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Shandong Hualu Pharmaceutical
14.19.1 Shandong Hualu Pharmaceutical Company Profile
14.19.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Specification
14.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Minsheng Pharma
14.20.1 Minsheng Pharma Company Profile
14.20.2 Minsheng Pharma Colloids (Blood Plasma) Product Specification
14.20.3 Minsheng Pharma Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.21 Kanglepharm
14.21.1 Kanglepharm Company Profile
14.21.2 Kanglepharm Colloids (Blood Plasma) Product Specification
14.21.3 Kanglepharm Colloids (Blood Plasma) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Colloids (Blood Plasma) Market Forecast (2022-2027)
15.1 Global Colloids (Blood Plasma) Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Colloids (Blood Plasma) Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Colloids (Blood Plasma) Value and Growth Rate Forecast (2022-2027)
15.2 Global Colloids (Blood Plasma) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Colloids (Blood Plasma) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Colloids (Blood Plasma) Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Colloids (Blood Plasma) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Colloids (Blood Plasma) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Colloids (Blood Plasma) Consumption Forecast by Type (2022-2027)
15.3.2 Global Colloids (Blood Plasma) Revenue Forecast by Type (2022-2027)
15.3.3 Global Colloids (Blood Plasma) Price Forecast by Type (2022-2027)
15.4 Global Colloids (Blood Plasma) Consumption Volume Forecast by Application (2022-2027)
15.5 Colloids (Blood Plasma) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
